FDA Eyes Alpharma's Embeda Over Abuse Effects
U.S. Food and Drug Administration officials are concerned that design features meant to cut down on abuse of Alpharma Inc.'s Embeda aren't enough to prevent addicts from misusing the potent painkiller....To view the full article, register now.
Already a subscriber? Click here to view full article